What I am working with: fatigue · orforglipron.
I can predict the outcome but I cannot explain it, which means I will get the next case wrong.
I would like to know how confident the field actually is about this.
Can someone derive this rather than assert it?
Answer first: fatigue in this context is usually an energy-intake problem before it is a drug effect, and the arithmetic is the first place to look.
A deficit beyond about a thousand kilocalories a day reliably produces fatigue, reduced training performance and reduced spontaneous movement. With appetite suppressed, deficits of that size arrive by accident rather than by plan.
| Feature | Local reaction | Sterile abscess | Cellulitis |
|---|---|---|---|
| Onset | Hours to 2 days | Days | 1–4 days, progressive |
| Warmth | Absent or minimal | Mild | Marked |
| Expansion | Static or shrinking | Slow | Expanding |
| Texture | Firm, flat or raised | Fluctuant | Diffuse, indurated |
| Systemic features | None | None | Fever, malaise possible |
| Action | Observe, rotate site | Clinical review | Same-day clinical review |
The relevant detail is that carbohydrate intake specifically affects training performance and perceived energy at a given total intake, which is why very low carbohydrate approaches feel worse in the gym at matched energy.
Ferritin as an acute-phase reactant is a recognised limitation and is why it is interpreted alongside an inflammatory marker.
The caveat is that fatigue with breathlessness, chest symptoms or sudden onset needs assessment rather than dietary adjustment.
If it persists at an adequate intake, get bloods rather than more theories.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsThe relevant physiology is that a large deficit reduces both available substrate and spontaneous activity, and the second is often mistaken for the first.
Iron deficiency is common, particularly in menstruating women, and low intake plus a reduced red-meat share makes it more likely. Ferritin is the test, and it is an acute-phase reactant so it needs interpreting alongside CRP.
Fatigue that appeared abruptly, rather than gradually with the deficit, is a different pattern and points away from intake.
Sleep is a variable here too, and no amount of eating fixes sleep debt.
The short version: check intake, check hydration, check iron and thyroid if it persists, and only then attribute it to the compound.
Hypothyroidism, sleep apnoea, depression and anaemia all present as fatigue and all become more likely rather than less in this population, so attribution to the compound should be a diagnosis of exclusion.
Stated carefully, three days of honest weighed intake usually settles this. Estimated intake in this situation is systematically wrong and usually wrong in the direction that hides the problem.
Attributing a symptom with a wide differential to the most recent change is a common and expensive error.
Weigh three days of intake honestly. That answers this most of the time.
The honest answer is that this is usually fixable by eating more, which is unwelcome advice in this context.
Dehydration from reduced fluid intake alongside reduced food intake produces headache, lethargy and postural dizziness, and is the cheapest thing on the list to correct.
Research-use compounds are not approved for human use.
Abrupt onset points away from the deficit and towards something else.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.